Novo Nordisk to Acquire Forma Therapeutics for US$1.1 B
By Ashish Tripathi
Pharma Deals Review: Vol 2022 Issue 9 (Table of Contents)
Published: 13 Sep-2022
DOI: 10.3833/pdr.v2022.i9.2721 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a bid to expand its presence in sickle cell disease and rare blood disorders, Novo Nordisk has agreed acquire Forma Therapeutics...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS